DE60033671D1 - Polyoxyalkylen-blockcopolymere enthaltende giessfähige flüssige träger - Google Patents

Polyoxyalkylen-blockcopolymere enthaltende giessfähige flüssige träger

Info

Publication number
DE60033671D1
DE60033671D1 DE60033671T DE60033671T DE60033671D1 DE 60033671 D1 DE60033671 D1 DE 60033671D1 DE 60033671 T DE60033671 T DE 60033671T DE 60033671 T DE60033671 T DE 60033671T DE 60033671 D1 DE60033671 D1 DE 60033671D1
Authority
DE
Germany
Prior art keywords
block copolymers
copolymers containing
compositions
polyoxyalkylene block
liquid vehicles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60033671T
Other languages
English (en)
Other versions
DE60033671T2 (de
Inventor
Douglas Joseph Dobrozsi
Jerry William Hayes
Bjorn Olof Lindman
Rouja Hristova Ivanova
Paschalis Alexandridis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Application granted granted Critical
Publication of DE60033671D1 publication Critical patent/DE60033671D1/de
Publication of DE60033671T2 publication Critical patent/DE60033671T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/90—Block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Otolaryngology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Paints Or Removers (AREA)
  • Lubricants (AREA)
  • Detergent Compositions (AREA)
  • Polyethers (AREA)
DE60033671T 1999-09-11 2000-09-11 Polyoxyalkylen-blockcopolymere enthaltende giessfähige flüssige träger Expired - Lifetime DE60033671T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15326099P 1999-09-11 1999-09-11
US153260P 1999-09-11
PCT/US2000/024732 WO2001019329A2 (en) 1999-09-11 2000-09-11 Polyoxyalkylene copolymers containing pourable liquid vehicles

Publications (2)

Publication Number Publication Date
DE60033671D1 true DE60033671D1 (de) 2007-04-12
DE60033671T2 DE60033671T2 (de) 2007-12-06

Family

ID=22546438

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60033671T Expired - Lifetime DE60033671T2 (de) 1999-09-11 2000-09-11 Polyoxyalkylen-blockcopolymere enthaltende giessfähige flüssige träger

Country Status (12)

Country Link
US (1) US6503955B1 (de)
EP (1) EP1212091B1 (de)
JP (1) JP2003509350A (de)
CN (1) CN1373674A (de)
AT (1) ATE355082T1 (de)
AU (1) AU770516B2 (de)
CA (1) CA2383570C (de)
DE (1) DE60033671T2 (de)
ES (1) ES2282134T3 (de)
MX (1) MXPA02002607A (de)
TR (1) TR200200616T2 (de)
WO (1) WO2001019329A2 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4803935B2 (ja) * 1999-10-08 2011-10-26 アフィニアム・ファーマシューティカルズ・インコーポレイテッド Ｆａｂｉ阻害剤
JP3553562B2 (ja) * 2000-08-25 2004-08-11 興和株式会社 イブプロフェンカプセル充填液及びカプセル製剤
WO2002041837A2 (en) * 2000-11-22 2002-05-30 Rxkinetix, Inc. Treatment of mucositis
EP1560584B1 (de) * 2001-04-06 2009-01-14 Affinium Pharmaceuticals, Inc. Fab-i-inhibitoren
US7138133B2 (en) 2001-10-10 2006-11-21 The Procter & Gamble Company Orally administered liquid compositions
FR2838349B1 (fr) * 2002-04-15 2004-06-25 Laurence Paris Compositions liquides pour capsules molle a liberation prolongee et leur procede de fabrication
DK1575951T3 (da) * 2002-12-06 2014-09-15 Debiopharm Int Sa Heterocykliske forbindelser, fremgangsmåder til fremstilling deraf og deres anvendelse i terapi
US20060140985A1 (en) * 2003-01-10 2006-06-29 Zhong Zhang Lansoprazole formulations and related processes and methods
JP4880448B2 (ja) 2003-03-17 2012-02-22 アフィナム ファーマシューティカルズ，インコーポレーテッド 複数の抗生物質を含む組成物、及びそれを用いる方法
JP2006008696A (ja) * 2003-03-20 2006-01-12 Mitsubishi Pharma Corp アルギニンアミド類を含有する医薬製剤
WO2004090613A1 (ja) * 2003-04-03 2004-10-21 Seed Co., Ltd. 薬物徐放性眼用レンズ及びそれに用いる保存液
US20050118261A1 (en) * 2003-06-12 2005-06-02 Oien Hal J. Compositions and methods of administering doxepin to mucosal tissue
AU2004305539B2 (en) * 2003-12-11 2010-09-02 Alcon, Inc. Ophthalmic compositions containing a polysaccharide/borate gelling system
WO2007053131A2 (en) 2004-06-04 2007-05-10 Affinium Pharmaceuticals, Inc. Acrylamide derivatives as antibiotic agents
CN1311873C (zh) * 2004-06-30 2007-04-25 上海复康医药科技发展有限公司 一种温度敏感的阴道用原位凝胶制剂
US20060115782A1 (en) * 2004-11-30 2006-06-01 Chunhua Li Systems and methods for coating a dental appliance
US7947508B2 (en) * 2004-11-30 2011-05-24 Align Technology, Inc. Systems and methods for intra-oral diagnosis
US20060115785A1 (en) 2004-11-30 2006-06-01 Chunhua Li Systems and methods for intra-oral drug delivery
US7766658B2 (en) * 2004-11-30 2010-08-03 Align Technology, Inc. Systems and methods for intra-oral diagnosis
WO2006091719A2 (en) * 2005-02-23 2006-08-31 Sontra Medical Corporation Compositions and methods enhancing transdermal delivery of drugs and biologics
WO2007064755A2 (en) * 2005-11-30 2007-06-07 Endo Pharmaceuticals Inc. Treatment of xerostomia with a sulfur-containing antioxidant
US20090156578A1 (en) * 2005-12-05 2009-06-18 PAULS Henry 3-Heterocyclylacrylamide Compounds as Fab I Inhibitors and Antibacterial Agents
US20070196329A1 (en) * 2006-01-20 2007-08-23 Erning Xia Disinfection efficacy of lens care regimen for rigid gas permeable contact lenses
WO2007104173A2 (de) * 2006-03-10 2007-09-20 Laboswiss Ag Verfahren zum solubilisieren, dispergieren und stabilisieren von stoffen, nach dem verfahren hergestellte erzeugnisse sowie die verwendung derselben
CA2658506C (en) 2006-07-20 2016-01-26 Affinium Pharmaceuticals, Inc. Acrylamide derivatives as fab 1 inhibitors
US8263613B2 (en) * 2007-02-16 2012-09-11 Affinium Pharmaceuticals, Inc. Salts, prodrugs and polymorphs of fab I inhibitors
WO2012135422A2 (en) 2011-04-01 2012-10-04 University Of Florida Research Foundation, Inc. Thermo-sensitive, mucoadhesive or dermoadhesive, and penetration-enhancing formulations for topical delivery of therapeutics
ITFI20110241A1 (it) * 2011-11-03 2013-05-04 Lo Li Pharma Srl Formulazioni per migliorare la probabilità di fecondazione ed il numero di gravidanze
KR101720885B1 (ko) 2012-06-19 2017-03-28 데비오팜 인터네셔날 에스 에이 (e)-n-메틸-n-((3-메틸벤조푸란-2-일)메틸)-3-(7-옥소-5,6,7,8-테트라히드로-1,8-나프티리딘-3-일)아크릴아미드의전구약물 유도체
UY36570A (es) * 2015-02-26 2016-10-31 Merial Inc Formulaciones inyectables de acción prolongada que comprenden un agente activo isoxazolina, métodos y usos de las mismas
LT3419628T (lt) 2016-02-26 2021-01-25 Debiopharm International Sa Medikamentas diabetinėms pėdų infekcijoms gydyti
WO2018144491A1 (en) 2017-02-01 2018-08-09 Johnson & Johnson Consumer Inc. A lozenge

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4100271A (en) 1976-02-26 1978-07-11 Cooper Laboratories, Inc. Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes
US4188373A (en) 1976-02-26 1980-02-12 Cooper Laboratories, Inc. Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes
US4478822A (en) 1983-05-16 1984-10-23 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels
US4474752A (en) 1983-05-16 1984-10-02 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels
US4511563A (en) 1983-07-15 1985-04-16 Basf Wyandotte Corporation Clear analgesic gels with reduced tackiness
AU6073386A (en) * 1985-07-30 1987-02-05 International Minerals & Chemical Corporation Stabilization of growth promoting hormones
DE3532562A1 (de) * 1985-09-12 1987-03-12 Dolorgiet Gmbh & Co Kg Transdermal resorbierbare, wasserhaltige zubereitungen von arylpropionsaeurederivaten und verfahren zur herstellung derselben
US5030448A (en) 1986-05-15 1991-07-09 Emory University Method of delivering drugs to damaged or diseased tissue
US4810503A (en) 1987-03-31 1989-03-07 Basf Corporation Polymers which form gels at low concentrations in water
US4911926A (en) 1988-11-16 1990-03-27 Mediventures Inc. Method and composition for reducing postsurgical adhesions
US5681576A (en) * 1988-11-16 1997-10-28 Mdv Technologies, Inc. Method and composition for post surgical adhesion reduction
US5135751A (en) 1988-11-16 1992-08-04 Mediventures Incorporated Composition for reducing postsurgical adhesions
US5256396A (en) 1990-01-24 1993-10-26 Colgate-Palmolive Company Topical composition
US5292516A (en) 1990-05-01 1994-03-08 Mediventures, Inc. Body cavity drug delivery with thermoreversible gels containing polyoxyalkylene copolymers
US5298260A (en) 1990-05-01 1994-03-29 Mediventures, Inc. Topical drug delivery with polyoxyalkylene polymer thermoreversible gels adjustable for pH and osmolality
US5306501A (en) 1990-05-01 1994-04-26 Mediventures, Inc. Drug delivery by injection with thermoreversible gels containing polyoxyalkylene copolymers
US5300295A (en) 1990-05-01 1994-04-05 Mediventures, Inc. Ophthalmic drug delivery with thermoreversible polyoxyalkylene gels adjustable for pH
US5143731A (en) 1990-08-07 1992-09-01 Mediventures Incorporated Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels
US5071644A (en) 1990-08-07 1991-12-10 Mediventures, Inc. Topical drug delivery with thermo-irreversible gels
US5346703A (en) 1990-08-07 1994-09-13 Mediventures, Inc. Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels
US5318780A (en) 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
CN1106259A (zh) 1994-02-05 1995-08-09 日东制药株式会社 含有作为有效成分的丙酸类非类固醇性药物的新颖消炎镇痛外用凝胶制剂
WO1997021441A1 (en) 1995-12-11 1997-06-19 Mdv Technologies, Inc. Ophthalmic composition comprising polyoxyethylene-polyoxypropylene polymers

Also Published As

Publication number Publication date
DE60033671T2 (de) 2007-12-06
TR200200616T2 (tr) 2002-06-21
WO2001019329A2 (en) 2001-03-22
ES2282134T3 (es) 2007-10-16
CA2383570C (en) 2008-08-12
EP1212091A2 (de) 2002-06-12
MXPA02002607A (es) 2002-07-30
EP1212091B1 (de) 2007-02-28
WO2001019329A3 (en) 2001-08-02
ATE355082T1 (de) 2006-03-15
AU7128200A (en) 2001-04-17
AU770516B2 (en) 2004-02-26
CN1373674A (zh) 2002-10-09
JP2003509350A (ja) 2003-03-11
US6503955B1 (en) 2003-01-07
CA2383570A1 (en) 2001-03-22

Similar Documents

Publication Publication Date Title
DE60033671D1 (de) Polyoxyalkylen-blockcopolymere enthaltende giessfähige flüssige träger
DE69934229D1 (de) Zusammensetzung zur entschichtung von photolack und organischen materialien von substratoberflächen
ATE446776T1 (de) Zusammensetzung zur gefässbeschichtung
WO2004028489A3 (fr) Rouge a levres comprenant un polymere sequence
DE69722635D1 (de) Behandlung von materialien zur verbesserung der behandlung von viskoelastische flüssigkeiten
ATE145231T1 (de) In wasser selbstdispergierende organopolysiloxan enthaltende zusammensetzungen
DE69840898D1 (de) Biostatische beschichtungen zur minderung und verhütung von bakterienansätzen
DE60023872D1 (de) Verfahren zur erhöhung der biologischen effektivität von zusammensetzungen zur pflanzenbehandlung
DE69812838D1 (de) Zusammensetzung und Verfahren zur Hemmung des Wachstums von Mikroorganismen auf der Grundlage von stabilisiertem Natriumhypobromit und Isothiazolonen
BR9407526A (pt) Composição de detergente de lavagem de louça em gel ou liquido concentrado contendo xileno sulfonato de cálcio
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
DE60013098D1 (de) Zusammensetzung zur hautdesinfizierung
CO5050275A1 (es) Composiciones liquidas para la limpieza de superficies duras
DE69802730D1 (de) Verfahren zur Verminderung des Schwefelgehalts einer Zusatzzusammensetzung.
FR2783708B1 (fr) Kit de maquillage associant des compositions filmogenes
DE69928820D1 (de) Akt zusammensetzungen zur steigerung des überlebens von kardiomyozyten
AU2002232491A1 (en) Compositions and methods for treating surfaces
ATE532761T1 (de) Keramische sanitärprodukte
DE69111768D1 (de) Enzymatische Zusammensetzung zur Bestimmung von Äthanol.
AR006028A1 (es) Composicion limpiadora que comprende endodextranasa, aditivo detergente que la comprende y aplicacion en composiciones limpiadoras
GB9819397D0 (en) Composition for the removal of biological and organic substances
DE69506842D1 (de) Verfahren zur Herstellung von granularen Waschmittelkomponenten oder Waschmittelzusammensetzungen
DE69818726D1 (de) Verfahren und Enzyme enthaltende Zusammensetzung zur Verbesserung des Enthaarens von Baumwollartikeln
AR017402A1 (es) Una composicion blanqueadora para eliminar manchas de sustratos, un metodo para blanquear un sustrato manchado y un metodo para inhibir el desarrollomicrobiano en sustratos de superficie flexible o dura
TW277071B (de)

Legal Events

Date Code Title Description
8364 No opposition during term of opposition